Protocadherin Beta 22 (Pcdhb22) is a member of the cadherin superfamily, a group of proteins that are primarily involved in mediating cell-cell adhesion in the nervous system. The protocadherins, including Pcdhb22, are believed to play a pivotal role in the development and function of neural circuits, contributing to the molecular diversity necessary for complex signaling and interactions among neurons. Pcdhb22, like other protocadherins, is characterized by its cadherin repeats, which are extracellular domains that facilitate adhesion through calcium-dependent homophilic interactions. These interactions are key for establishing the specificity of neuronal connections. The precise expression pattern of Pcdhb22 suggests a potentially important role in the wiring and function of particular neural networks. Understanding the regulation of Pcdhb22 is of interest to researchers who are exploring the molecular mechanisms that govern neural development and plasticity.
Research into the molecular biology of gene expression has identified various chemical compounds that can potentially stimulate the expression of specific genes like Pcdhb22. Chemical activators can induce gene expression by interacting with cellular mechanisms that regulate transcription. For example, compounds that inhibit DNA methyltransferases, such as 5-Aza-2'-deoxycytidine, could lead to the demethylation of gene promoter regions, removing silencing marks and increasing gene expression. Histone deacetylase inhibitors, such as Trichostatin A and Valproic acid, may promote a more transcriptionally active chromatin state, allowing easier access for transcription factors and RNA polymerase to the Pcdhb22 gene, thereby potentially stimulating its expression. Other compounds like Forskolin might raise intracellular second messengers (e.g., cAMP), which can activate signaling cascades that ultimately lead to the upregulation of gene transcription. Such activators work through a diverse array of mechanisms, but they share the common goal of altering the cellular environment in a way that can lead to an increase in the targeted gene expression. Understanding these mechanisms offers insights into the natural regulation of genes like Pcdhb22 and provides a foundation for exploring the complex interplay between cellular signaling and gene expression in the context of neural development.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
This compound could hypothetically demethylate cytosine bases within the promoter region of Pcdhb22, leading to an upsurge in transcriptional activity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
By inhibiting histone deacetylases, Trichostatin A could promote acetylation of histones, facilitating a transcriptionally active chromatin state at the Pcdhb22 gene locus. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
May upregulate Pcdhb22 by creating an accessible chromatin configuration, enabling transcription factors to interact more effectively with the Pcdhb22 promoter. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Could induce Pcdhb22 by engaging with retinoic acid receptors that bind to retinoic acid response elements in the gene's promoter region, initiating transcription. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
By stimulating adenylate cyclase, Forskolin could elevate cAMP, thereby activating protein kinase A which may enhance the transcription of Pcdhb22. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This green tea derivative could stimulate Pcdhb22 transcription by altering DNA methylation patterns and histone modifications within the gene's regulatory regions. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
May upregulate Pcdhb22 by binding to the vitamin D receptor, which interacts with vitamin D response elements in the regulatory regions of the gene. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Could augment the expression of Pcdhb22 by inducing hyperacetylation of histones in the gene's promoter region, promoting a more relaxed chromatin state conducive to transcription. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
This polyphenolic compound may stimulate Pcdhb22 expression by activating sirtuins which then modulate the chromatin landscape around the gene's regulatory elements. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Could induce Pcdhb22 expression by inhibiting histone acetyltransferases, leading to transcriptional activation of genes silenced by histone deacetylation. | ||||||